Last reviewed · How we verify
Complete a 7-day course
Complete a 7-day course is a Small molecule drug developed by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. It is currently FDA-approved. Also known as: Completion of the antibiotic course.
At a glance
| Generic name | Complete a 7-day course |
|---|---|
| Also known as | Completion of the antibiotic course |
| Sponsor | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer (PHASE2)
- Natural History Study for Patients With Nemaline Myopathy in Belgium (NA)
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure (PHASE1)
- Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (PHASE2, PHASE3)
- PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer (PHASE2, PHASE3)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients (PHASE2)
- Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN) (PHASE2)
- Asthma and Technology in Emerging African American Adults (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Complete a 7-day course CI brief — competitive landscape report
- Complete a 7-day course updates RSS · CI watch RSS
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina portfolio CI
Frequently asked questions about Complete a 7-day course
What is Complete a 7-day course?
Complete a 7-day course is a Small molecule drug developed by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina.
Who makes Complete a 7-day course?
Complete a 7-day course is developed and marketed by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (see full Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina pipeline at /company/fundacio-d-investigacio-en-atencio-primaria-jordi-gol-i-gurina).
Is Complete a 7-day course also known as anything else?
Complete a 7-day course is also known as Completion of the antibiotic course.
What development phase is Complete a 7-day course in?
Complete a 7-day course is FDA-approved (marketed).
Related
- Manufacturer: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina — full pipeline
- Also known as: Completion of the antibiotic course
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing